You are here: Home News May 19th 2016 Free Webinar ECG Assessment in Early Phase 1 Studies: How to get it right for possible TQT waiver?

May 19th 2016 Free Webinar ECG Assessment in Early Phase 1 Studies: How to get it right for possible TQT waiver?

In partnership with Banook Group and Phaster 1, PhinC Development organizes a free webinar on May 19th, 2016 at 5:00 PM

Webinar Agenda:
Session 1
10 years from “ICH E14” to “ICH E14 Q&A (R3)”


The purpose of the presentation is first to assess the implementation IQT (intensive QT) study as an alternative to the TQT studies; then to assay sensitivity in IQT Studies.

Session 2
Implementation of “ICHE14 Q&A (R3)”


Taking into account that the priority is to generate guidance on concentration-response modelling, the exposure response as an alternative to IUT analysis will be assessed during this presentation as well as the usage of adequate modeling and definitions for a negative drug.

Speakers will be:

Mathieu Felices, Pharmacometrician & Biostatistician at PhinC Development

Pierre Maison-Blanche - MD – Senior Advisor at Banook Group

Thierry Duvauchelle – MD - Clinical Pharmacologist at Phaster 1

Are you interested in this webinar?

Registration is here, be careful number of places is limited!

(You will receive all the information about the connection to the Webinar as soon as your registration is confirmed)

We hope this agenda will please you, do not hesitate to prepare and send us all your questions on the subject when you register!